Inogen Inc. (INGN)
Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Manufacturing · CIK 1294133 · fiscal year ends in Dec
Closing price $6.87 on 30 Oct 2026; 52-week range $5.09 to $8.24.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $354.3M
- Revenue growth
- 3.2%
- Net income, last twelve months
- -$24.6M
- Earnings per share
- -$0.90
- Gross margin
- 44.5%
- Operating margin
- -8.7%
- Net margin
- -6.9%
- Free cash flow
- -$5.0M
- Return on equity
- -14.1%
- Market value
- $183.6M
- Cash
- $87.3M
- Debt
- $0
- Debt to equity
- 0.00
- Shares outstanding
- 26.7M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $348.7M | -$30.2M | -$22.7M | -$0.86 | -$13.7M | 10-K filed 27 Feb 2026 |
| FY2024 | 31 Dec 2024 | $335.7M | -$42.5M | -$35.9M | -$1.52 | $2.6M | 10-K filed 28 Feb 2025 |
| FY2023 | 31 Dec 2023 | $315.7M | -$109.4M | -$102.4M | -$4.42 | -$8.5M | 10-K filed 1 Mar 2024 |
| FY2022 | 31 Dec 2022 | $377.2M | -$85.2M | -$83.8M | -$3.67 | -$40.9M | 10-K filed 24 Feb 2023 |
| FY2021 | 31 Dec 2021 | $358.0M | $9.2M | -$6.3M | -$0.28 | $18.2M | 10-K filed 24 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $95.1M | -$3.9M | -$0.14 |
| Q1 FY2026 | 31 Mar 2026 | $85.1M | -$8.3M | -$0.30 |
| Q4 FY2025 | 31 Dec 2025 | $81.7M | -$7.1M | -$0.26 |
| Q3 FY2025 | 30 Sep 2025 | $92.4M | -$5.3M | -$0.20 |
| Q2 FY2025 | 30 Jun 2025 | $92.3M | -$4.2M | -$0.15 |
| Q1 FY2025 | 31 Mar 2025 | $82.3M | -$6.2M | -$0.25 |
| Q4 FY2024 | 31 Dec 2024 | $80.1M | -$9.8M | -$0.41 |
| Q3 FY2024 | 30 Sep 2024 | $88.8M | -$6.0M | -$0.25 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By region, FY2025
| Segment | Revenue | Share |
|---|---|---|
| United States | $209.8M | 60.2% |
| International revenue | $138.8M | 39.8% |
Company events
The newest 8-K filings of 145 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 30 Sep 2026 | 8-K | Material agreement, Investor update, Other events | 1.01, 7.01, 8.01, 9.01 |
| 6 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 1 Jul 2026 | 8-K | Leadership change, Investor update | 5.02, 7.01, 9.01 |
| 11 Jun 2026 | 8-K | Leadership change, Shareholder vote | 5.02, 5.07, 9.01 |
| 7 May 2026 | 8-K | Results | 2.02, 9.01 |
| 6 Apr 2026 | 8-K | Leadership change, Material agreement, Investor update | 1.01, 5.02, 7.01, 9.01 |
| 30 Mar 2026 | 8-K | Leadership change, Investor update | 5.02, 7.01, 9.01 |
| 24 Feb 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 12 Jan 2026 | 8-K | Results | 2.02, 9.01 |
| 5 Nov 2025 | 8-K | Results | 2.02, 9.01 |
| 7 Aug 2025 | 8-K | Results | 2.02, 9.01 |
| 29 Jul 2025 | 8-K | Leadership change | 5.02 |
Every filing
The newest filings with the SEC of 303 held.
| Filed | Form | Period |
|---|---|---|
| 30 Sep 2026 | 8-K | 28 Sep 2026 |
| 7 Aug 2026 | 10-Q | 30 Jun 2026 |
| 6 Aug 2026 | 8-K | 6 Aug 2026 |
| 24 Jul 2026 | S-8 | – |
| 1 Jul 2026 | 8-K | 1 Jul 2026 |
| 12 Jun 2026 | S-8 | – |
| 11 Jun 2026 | 8-K | 5 Jun 2026 |
| 28 May 2026 | SD | – |
| 8 May 2026 | 10-Q | 31 Mar 2026 |
| 7 May 2026 | 8-K | 7 May 2026 |
| 4 May 2026 | S-8 | – |
| 28 Apr 2026 | ARS | 31 Dec 2025 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 1 Jul 2026 | Yi Boyer Jennifer M, EVP Entrprs Enblmnt, Ch HR Off | Sale under a trading plan | 10,938 | $6.60 | $72.1K | 5,039 | 6 Jul 2026 |
| 29 May 2026 | Yi Boyer Jennifer M, EVP Entrprs Enblmnt, Ch HR Off | Sale under a trading plan | 10,770 | $6.53 | $70.3K | 15,977 | 2 Jun 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 1 Jul 2026 | JENNIFER YI BOYER, Officer | 10,938 | $70.6K | 1 Jul 2026 |
| 29 May 2026 | JENNIFER YI BOYER, Officer | 10,770 | $70.4K | 29 May 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 1.5M | +3.88% | 4.1 |
| 30 Sep 2026 | 1.5M | +7.87% | 3.65 |
| 15 Sep 2026 | 1.4M | -6.59% | 5.14 |
| 31 Aug 2026 | 1.5M | +1.66% | 6.49 |
| 14 Aug 2026 | 1.4M | +14.31% | 4.9 |
| 31 Jul 2026 | 1.3M | +19.48% | 6.27 |
| 15 Jul 2026 | 1.1M | +2.61% | 5.24 |
| 30 Jun 2026 | 1.0M | +15% | 3.69 |
Funds that hold it
From each fund's latest Form 13F.
142 funds held it at 30 Jun 2026: 81 added and 30 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 1,748,986 | $11.3M | +101,902 |
| Armistice Capital, LLC | 1,096,000 | $7.1M | -104,000 |
| Acadian Asset Management LLC | 1,096,879 | $7.1M | +13,396 |
| Vanguard Capital Management LLC | 1,038,316 | $6.7M | +1,611 |
| Ameriprise Financial Inc. | 983,028 | $6.3M | +123,485 |
| AQR Capital Management LLC | 937,334 | $6.0M | +510,216 |
| Dafna Capital Management LLC | 845,179 | $5.5M | 0 |
| Arrowstreet Capital, Limited Partnership | 743,252 | $4.8M | +157,093 |
| Morgan Stanley | 646,276 | $4.2M | +105,111 |
| Geode Capital Management, LLC | 641,521 | $4.1M | +27,992 |
Peers
Companies in the same industry.
- Intuitive Surgical Inc. (ISRG): revenue $11.6B, market value $149.8B
- Edwards Lifesciences Corp. (EW): revenue $6.5B, market value $53.1B
- Steris plc (STE): revenue $6.0B, market value $22.1B
- Zimmer Biomet Holdings, Inc. (ZBH): revenue $8.5B, market value $18.0B
- Smith & Nephew plc (SNN): revenue $6.2B, market value $13.0B
- Align Technology Inc. (ALGN): revenue $4.1B, market value $10.7B
- MSA Safety Inc. (MSA): revenue $1.9B, market value $6.9B
- Establishment Labs Holdings Inc. (ESTA): revenue $245.8M, market value $1.9B
- Cadre Holdings, Inc. (CDRE): revenue $685.6M, market value $1.3B
- Enovis Corp. (ENOV): revenue $2.3B, market value $1.1B